SARS-CoV-2 receptor binding domain-specific antibodies activate platelets with features resembling the pathogenic antibodies in heparin-induced thrombocytopeniaWen Zhu, Renren Wen, Yongwei Zheng et al.|Research Square|2021Cited by 6
Prothrombotic antibodies targeting the spike protein's receptor-binding domain in severe COVID-19Wen Zhu, Renren Wen, Yongwei Zheng et al.|Blood|2024Cited by 5
Abstract B039: T-cell–dominated interferon signaling drives immune checkpoint inhibitor–associated pneumonitis and reveals actionable cytokine targetsPaytsar Topchyan, Alexandra Drakaki, Willy Hugo et al.|Cancer Immunology Research|2026Cited by 0